Roche moves obesity drug to pivotal trials after mid-stage success
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Number of new U.S. drug shortages hits lowest level in 20 years
The number of ongoing prescription drug shortages rose slightly in the last quarter of 2025, but remained significantly…
Slingshot pulls therapy chatbot Ash out of UK over regulatory concerns
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
We’re reading about Canada speeding drug reviews, Novo ads
Rise and shine, everyone, another busy day is headed your way. And it is getting off to a…
Secretive Project Prometheus takes VC Bob Nelsen beyond just health care
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and…
FDA relaxes oversight of AI-enabled devices and wearables
Food and Drug Administration Commissioner Marty Makary.ANDREW CABALLERO-REYNOLDS/AFP via Getty Images Lizzy Lawrence leads STAT’s coverage of the…
Neuralink’s big vision collides with reality of brain implants
O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming…
FDA voucher program has led to political interference in drug reviews, staffers say
WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…
Meta urged by state AGs to regulate weight loss drug ads
More than three dozen state attorneys general are urging Meta to better enforce its policies to thwart a…
AI firms believe mammograms can spot multiple health risks
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
In radiology, AI is advancing faster than the field can keep up
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
Regulatory reform can unlock access to biosimilars
Every day, I think about the patients waiting for medicines that could change, or even save, their lives.…